WebPatents Assigned to DYBLY AG Preparation of condensed triazepine derivatives and their use as BET inhibitors. Patent number: 10906917 Abstract: The invention relates to compounds of the formula: and pharmaceutically acceptable salts thereof. These compounds are useful in the treatment of inflammatory diseases, fibtrotic diseases and … WebHe was also the co-founder of Dybly AG, a Basel-based cardiovascular company. Read More. Jobs. Edit Jobs Section. Number of Current Jobs 3. Rolf Jan Rutten has 3 current jobs including Venture Partner at ScaleUp, CEO and co-founder at thromboDx BV, and Founder and Chief Executive Officer at Audion Therapeutics.
Patents Assigned to DYBLY AG - Justia Patents Search
WebDYBLY AG has a total of 17 patent applications. Its first patent ever was published in 2008. It filed its patents most often in WIPO (World Intellectual Property Organization), … Web开馆时间:周一至周日7:00-22:30 周五 7:00-12:00; 我的图书馆 how fast can a viper go
Dybly Ltd, Basel, Switzerland
WebDybly AG Company Profile Basel, BASEL-STADT, Switzerland Competitors, Financials & Contacts - Dun & Bradstreet. HOME. / BUSINESS DIRECTORY. / PROFESSIONAL, … WebDybly Ltd, Basel, Switzerland Dybly developed pharmaceutical products for patients affected by inflammatory and fibrotic diseases. Since 2024, all Dybly's programs have … Investors / History - Dybly Ltd, Basel, Switzerland Dybly developed pharmaceutical products for patients affected by inflammatory … Contact - Dybly Ltd, Basel, Switzerland Links - Dybly Ltd, Basel, Switzerland WebAssignee: DYBLY AG Inventors: Herman Kempen, Adel Far PREPARATION OF CONDENSED TRIAZEPINE DERIVATIVES AND THEIR USE AS BET INHIBITORS. Publication number: 20240231598 Abstract: The invention relates to compounds of the formula: and pharmaceutically acceptable salts thereof. These compounds are useful in … high court personal injury summons